Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-04 | 2024-06-03 | ORIC | Kunkel Lori Anne | Dir | M - OptEx | $3.75 | +20.5K | 20.5K | New | +$76.9K |
| D | 2024-06-04 | 2024-06-03 | ORIC | Kunkel Lori Anne | Dir | M - OptEx | $0.00 | -20.5K | 33.2K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | M | A | 20,500 | $3.75 | 20,500 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-03 | M | D | 20,500 | $0.00 | 33,200 | D | $3.75 · — to 2032-06-16 | 20,500 Common Stock | (F1) (A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022. |